Thursday, February 12, 2015

Saving Lives at Birth: A Grand Challenge for Development [Grants]

SAVING LIVES AT BIRTH ROUND 5
 
The Saving Lives at Birth: A Grand Challenge for Development partners invite global problem solvers to answer their fifth call for groundbreaking prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the time of childbirth.

The Challenge seeks to identify and develop transformative approaches that integrate new technologies, better service delivery models and improved "demand side" innovations that empower pregnant women and their families to practice healthy behaviors and be aware of and access health care during pregnancy, childbirth and the early postnatal period, especially the first two days after birth

This year, in addition to the seed and transition awards used in previous rounds, the partners introduced a third funding stream.  'Validation' funds will be used to introduce and validate the effectiveness of innovations to reach proof-of-concept. Round 5 will also place an increased focus on advancing the most successful and transformational innovations as they transition to scale. The actual number of awards in each category varies.

The Challenge will be accepting applications starting February 16 through March 27, 2015 (closes at 2:00 p.m. ET).

For more information, join the Twitter Chat on February 12 and visit www.savinglivesatbirth.net/apply. ***

Twitter Chat

To herald the launch of Round 5, join us for a live #SavingLivesRd5 Twitter chat this Thursday, February 12th at 10 a.m. - 11 a.m. ET. Joined by a panel of MNCH experts, Saving Lives at Birth will focus the discussion on the future of maternal and newborn health innovation. Follow @GCDSavingLives and #SavingLivesRd5 to participate. We hope you will join!

Saving Lives at Birth: A Grand Challenge for Development partnership, launched in 2011, includes the U.S. Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada (funded by the Government of Canada), and the U.K’s Department for International Development (DFID).

***The Challenge

USAID, the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and DFID have joined together to launch Saving Lives at Birth: A Grand Challenge for Developmentto find the tools and approaches to help the mothers and newborns during their most vulnerable hours.
We seek groundbreaking prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the time of delivery. 
This is the period when the majority of maternal and newborn deaths occur and the population that has been the most difficult to reach.
We seek innovative ideas that can leapfrog conventional approaches in three main domains: (1) technology; (2) service delivery; and (3) “demand side” innovation that empowers pregnant women and their families to practice healthy behaviors and be aware of and access health care during pregnancy, childbirth and the early postnatal period, especially the first two days after birth.

Seeking Breakthroughs

Significant breakthroughs in innovation often come about when new ideas and disciplines are applied to long-entrenched problems.  New technologies and approaches transform insurmountable development challenges into solvable problems. To harness this ingenuity, we encourage partnerships that bring together diverse expertise from non-traditional partners. And to foster sustainability, we encourage the private sector to bring their expertise and experience to bear on these problems. 

How It Works

Five partners - USAID, the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and DFID -  came together to support this single challenge. The World Bank is also an affiliate of this program. Projects will be jointly selected through a unified application process. Successful innovators will be funded and managed independently by one of two funding mechanisms – pooled resources from USAID, the Bill & Melinda Gates Foundation, and the Government of Norway, or Grand Challenges Canada – and supported collectively as a community of innovators by all five partners.

Building a Community of Innovators

Partners will work with this community to foster learning and continued innovation.  Awardees will receive support and networking assistance from each of the partners, engage with other innovators, and participate in high-level meetings including the Bill & Melinda Gates Foundation’s annual Grand Challenge meetings.

Types of Awards

We will invest in a portfolio of projects.  Through this portfolio, we will seek groundbreaking innovations by providing: 
  • Seed Funds to support the development and validation of ideas capable of impacting health outcomes for pregnant women and their babies in low-resource settings, 
  • Validation Funds to introduce and validate the effectiveness of innovations to reach proof-of-concept, and
  • Transition to Scale Funds to develop, refine, and rigoursly test the impact of integrated solutions that have previously measured promising health outcomes in a controlled or limited setting and have the potential to credibly scale to improve the lives of millions of pregnant women and newborns in multiple countries.  Transition funding is limited to integrated solutions that unite technology, service delivery, and demand. 

Key Features

  • A brief application.
  • Rapid turnaround time. We aim to select awards within 5 months from the proposal submission deadline.
  • Opportunities for shared learning and collaboration among innovators, funders and other public health experts.
  • A review process designed to identify potentially groundbreaking ideas that show great promise. 

What We’re Looking For

Interventions that:
  • Substantially increase demand for and access to primary health interventions for women and newborns (for example, by at least 50 percent for interventions with low coverage);
  • Substantially improve the quality of care as measured by health outcomes; and
  • Improve and sustain healthy behavior.

Solutions Should

  • Be "off the beaten track," daring in premise, and clearly differentiated from standard practice; 
  • Enhance uptake, acceptability and provide for sustained use (potential for sustainability as defined as cost-recovery, sustained use, and sustainable impact);
  • Be low-cost or highly cost-effective solutions;
  • Have a strong likelihood of achieving a substantial impact on one or more important adverse maternal, fetal, or neonatal health conditions;
  • Be scalable in resource-poor settings;
  • Be able to be monitored, measured and evaluated.

Wednesday, February 11, 2015

Global Health and Innovative Technology Fund - Funding announcements

The Global Health Innovative Technology (GHIT) Fund is announcing the following funding opportunities accepting proposals:

◆ Target Research Platform in partnership with Grand Challenges (TRP)
This program focuses on early stage development of drugs, vaccines or diagnostics to prevent and treat Malaria, TB, Chagas disease and Leishmaniasis.
Please visit the website for key dates, RFP and Intent to Apply form >>> https://www.ghitfund.org/afag/trp/en

◆ Product Development Platform
This is the GHIT Fund's conventional "grant" program which covers preclinical and clinical studies and registration of new drugs, vaccines and diagnostics for Malaria, TB and NTDs.
Please visit their website for key dates, RFP and Intent to Apply form >>> https://www.ghitfund.org/afag/grant/en

Please see the links above for full details, and do not hesitate to get in touch with Paul, Glad, or Tim, at the Office of Research Services if you have any further questions, or if you are interested in applying.

Thursday, January 22, 2015

Fogarty HIV Research Training Program

Announcement(s)

Deadlines

  • Letter of Intent Due Dates: 30 days before the application due date
  • Upcoming Application Due Dates: July 24, 2014; July 30, 2015

Eligibility

Program Overview


The overall goal of the Fogarty HIV Research Training Program is to strengthen the human capacity to contribute to the ability of institutions in low- and middle-income countries (LMIC) to conduct HIV-related research on the evolving HIV-related epidemics in their country and to compete independently for research funding. (See The World Bank Country and Lending Groups to identify countries with low- or middle-income economies.)
With co-funding from other NIH Institutes, Centers and Offices, Fogarty has provided 25 years of support to HIV research through two HIV research training programs: the AIDS International Training and Research Program (AITRP) and the International Clinical, Operations and Health Services Research Training Award for AIDS TB program (ICOHRTA AIDS TB). Fogarty has consolidated these two programs into the new Fogarty HIV Research Training Program.
While the areas for training permitted under the new program will be broad - to include HIV-related research and selected critical research infrastructure areas - each application should focus on building or strengthening capacity in a particular scientific or critical research infrastructure area at a LMIC institution. Applicant organizations may submit more than one application, provided that each application is programmatically and scientifically distinct.
The new program will move beyond simple output indicators (number and type of people trained) to outcome indicators (increased research capacity at an institutional level) for more meaningful monitoring and evaluating both of individual awards and of the program as a whole. It is anticipated that this approach will allow applicants to be more responsive to an emerging need at an LMIC institution for research capacity, and will provide more opportunities for LMIC institutions to collaborate with NIH and other U.S. government funded efforts.

Global Infectious Disease Research Training Program (GID)

Announcement(s)

Deadlines

  • Deadlines for D43 and D71 letters of intent:
    30 days prior to the application due date
  • Deadlines for D43 and D71 applications:
    July 29, 2014; July 29, 2015; July 29, 2016

Eligibility

Eligibility: Global Infectious Disease Research Training Program (D43)
  • U.S. Institutions with a demonstrated collaboration with a researcher in low- and middle-income country (LMIC) institutions may apply.
  • Foreign institutions in LMICs may also apply.
  • Applicant institution must have robust and high-quality research ongoing in the area(s) proposed.
Eligibility: Planning Grant for Global Infectious Disease Research Training Program (D71)
  • Applicants may only be submitted by foreign institutions in LMICs, as defined by theWorld Bank Classification system.
  • Foreign applicants should apply in collaboration with U.S. institutions and must name an individual in the proposed institution as the major collaborator.
Applicant institutions for both the full institutional grant and the planning grant may submit more than one application, provided that each application is scientifically distinct.

Program Overview


The Global Infectious Disease (GID) program addresses research training needs related to infectious diseases that are predominantly endemic in or impact upon people living in developing countries. The training programs include a variety of research training options to match the needs of the developing country institution. The ultimate goal is to build a critical mass of researchers and support staff to conduct independent infectious disease research in developing country institutions.
Training programs may include:
  • Long-term (master's or doctoral degree and other training that is six months or longer) training for the full range of skills necessary to support research and research administration with the understanding that the focus of thesis and training-related research will be in their country.
  • Medium-term (three- to up to six-months) training or mentoring, including specialized clinical, laboratory, research or administrative/business skills necessary to support research that is planned or ongoing.
  • Short-term (less than three months) training or mentoring that focuses on research methodology, laboratory skills necessary to support research ethics and compliance issues, program and grants administration and financial management, grant writing, preparation of scientific manuscripts, data management, informatics, and other relevant areas.
  • Institutional capacity-building efforts such as in-country training workshops in advanced research techniques, distance learning and informatics.
  • Advanced in-country mentored research undertaken by the trainee in his/her home country upon completion of his/her initial period of long-term training under the program.

International Research Ethics Education and Curriculum Development Award (Bioethics) (R25) (PAR-13-027)


NIH are currently requesting applications for the International Research Ethics Education and Curriculum Development Award (Bioethics).


Deadlines

Letter of intent due date: April 22, 2015
Application due date: May 22, 2015

Award Budget

New education program applications may request a budget of up to $230,000 direct costs per year.
Renewal education  program applications may request a budget of up to $276,000 direct costs per year.

Award Project Period

The total project period for a new or renewal application submitted in response to this funding opportunity may not exceed 5 years.  

Eligibility
Applications from foreign organizations must be from institutions located in countries defined by The World Bank as low income, lower-middle income or upper-middle income. See The World Bank Country and Lending Groups to identify countries with low- or middle-income economies.

Applicants are encouraged to collaborate with Fogarty Research and Research Training programs, or with other NIH grantees working in the developing countries where trainees are recruited. Collaboration with partners (listed below) is also encouraged.
View full eligibility in the program announcement.
Full Funding Announcement: 

http://grants.nih.gov/grants/guide/pa-files/PAR-13-027.html

Program Overview

The purpose of the International Research Ethics Education and Curriculum Development Award is to develop master's level curricula and provide educational opportunities for developing country academics, researchers and health professionals in ethics related to performing research involving human subjects in international resource poor settings. The goal of this initiative is to increase the number of developing country scientists, health professionals and relevant academics with in-depth knowledge of the ethical considerations, concepts and applications in clinical and public health research. It is expected that such master's level training will enhance the career development of individuals from developing countries, as well as strengthen and sustain the capacity to support ethical clinical and public health research at their home institutions and countries.

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (mHealth) (R21) (PAR-14-028)


This is a reminder that the deadline for the NIH R21 Grant for Mobile Health: Technology and Outcomes in Low and Middle Income Countries is approaching.

Deadlines

Application due date: February 19, 2015

Eligibility

Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution (with LMIC defined by The World Bank as low-, lower-middle-, or upper-middle-income economies).
Program Directors/Principal Investigators may be employed in either a U.S. or LMIC institution, but should plan to build capacity in mHealth research in the LMIC institution(s).
See full Eligibility Information for more details.

Award Budget
Applicants may request up to $125,000 direct costs per year.


Award Project Period
The total project period may not exceed 2 years.

Full Funding Announcement:


http://grants.nih.gov/grants/guide/pa-files/PAR-14-028.html


Program Overview
Mobile Health: Technology and Outcomes in Low and Middle Income Countries will support research on the development or adaptation of mobile health (mHealth) technology specifically suited for low- and middle-income countries (LMICs) and the health-related outcomes associated with implementation of the technology.

The program aims to contribute to the evidence base for the use of mobile technology to improve clinical outcomes and public health while building research capacity in LMICs and establishing research networks in this area. In the context of this program, mHealth includes the use of mobile and wireless devices (cell phones, tablets, etc.) to improve health outcomes, health care services and health research. The mHealth technology that is developed or adapted in proposed projects can include external hardware and/or software components for mobile or wireless devices.

Of highest interest are well-designed multidisciplinary projects that focus on tools or interventions for chronic diseases or technology for disease agnostic and/or crosscutting applications. See the full program announcement for details on the specific research interests of the participating NIH Institutes and Centers.

Tuesday, January 20, 2015

Medicines for Malaria Call for Proposals

MMV e-news. Defeating Malaria Together. 
Experiencing problems reading this email? View it in your browser.
MMV•••   Medicines for Malaria Venture
MMV welcomes proposals in the following four areas:

1. Compounds addressing the key priorities of the malaria eradication agenda

2. Assays addressing liver stage vivax

3. Asexual liver and blood stages

4. Resistant strains

Please visit MMV's website for detailed information.

All applications, using the templates on our website, should be sent to: proposals@mmv.org

Submission deadline: 12 noon CET Tuesday, 31 March 2015.
Original banner photo supplied by Sally-Ann Poulsen and Brett Schwartz, Eskitis Institute for Drug Discovery, Griffith University

Copyright © 2015 Medicines for Malaria Venture (MMV), All rights reserved.

Medicines for Malaria Venture (MMV)
PO Box 1826
Route de Pré-Bois, 20
Geneva 1215
Switzerland